A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma

Journal of Experimental Medicine

Volumn 183, Issue 6, 1996, Pages 2501-2508

  Brändle, Daniel ^b   Brasseur, Francis ^c   Weynants, Patrick ^c   Boon, Thierry ^c   Van Den Eynde, Benoît J ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^b Sandoz Pharma Ltd   (Switzerland)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

HLA A2 ANTIGEN;

ANTIGEN RECOGNITION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; HLA SYSTEM; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; MELANOMA; PRIORITY JOURNAL;

AGED; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CARCINOMA, RENAL CELL; CELL LINE; CERCOPITHECUS AETHIOPS; CYTOTOXICITY, IMMUNOLOGIC; DNA PRIMERS; GENE LIBRARY; GENES, MHC CLASS I; HLA-A2 ANTIGEN; HUMANS; KIDNEY NEOPLASMS; MODELS, STRUCTURAL; MOLECULAR SEQUENCE DATA; POINT MUTATION; POLYMERASE CHAIN REACTION; PROTEIN STRUCTURE, SECONDARY; RECOMBINANT PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029939743     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.6.2501     Document Type: Article

References (55)

1. van der Bruggen, P., C. Traversari, P. Chomez, C. Lurquin, E. De Plaen, B. Van den Eynde, A. Knuth, and T. Boon. 1991. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (Wash. DC.) 254:1643-1647.
2. Traversari, C., P. van der Bruggen, I.F. Luescher, C. Lurquin, P. Chomez, A. Van Pel, E. De Plaen, A. Amar-Costesec, and T. Boon. 1992. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J. Exp. Med. 176:1453-1457.
3. Gaugler, B., B. Van den Eynde, P. van der Bruggen, P. Romero, J.J. Gaforio, E. De Plaen, B. Lethé, F. Brasseur, and T. Boon. 1994. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med. 179:921-930.
4. Boël, P., C. Wildmann, M.-L. Sensi, R. Brasseur, J.-C. Renauld, P. Coulie, T. Boon, and P. van der Bruggen. 1995. BAGE, a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity. 2: 167-175.
5. Van den Eynde, B., O. Peeters, O. De Backer, B. Gaugler, S. Lucas, and T. Boon. 1995. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J. Exp. Med. 182:689-698.
6. Brichard, V., A. Van Pel, T. Wölfel, C. Wölfel, E. De Plaen, B. Lethé, P. Coulie, and T. Boon. 1993. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178:489-495.
7. Coulie, P.G., V. Brichard, A. Van Pel, T. Wölfel, J. Schneider, C. Traversari, S. Mattei, E. De Plaen, C. Lurquin, J.-P. Szikora et al. 1994. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 180:35-42.
8. Kawakami, Y., S. Eliyahu, C.H. Delgado, P.F. Robbins, L. Rivoltini, S.L. Topalian, T. Miki, and S.A. Rosenberg. 1994. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA. 91:3515-3519.
9. Kwon, B.S., C. Chintamaneni, C.A. Kozak, N.G. Copeland, D.J. Gilbert, N. Jenkins, D. Barton, U. Francke, Y. Kobayashi, and K.K. Kim. 1991. A melanocyte-specific gene, Pmel 17, maps near the silver coat color locus on mouse chromosome 10 and is a syntenic region on human chromosome 12. Proc. Natl. Acad. Sci. USA. 88:9228-9232.
10. Bakker, A.B.H., M.W.J. Schreurs, A.J. de Boer, Y. Kawakami, S.A. Rosenberg, G.J. Adema, and C.G. Figdor. 1994. Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J. Exp. Med. 179:1005-1009.
11. Mattes, M.J., T.M. Thomson, L.J. Old, and K.O. Lloyd. 1983. A pigmentation-associated, differentiation antigen of human melanoma defined by a precipitating antibody in human serum. Int. J. Cancer. 32:717-721.
12. Coulie, P.G., F. Lehmann, B. Lethé, J. Herman, C. Lurquin, M. Andrawiss, and T. Boon. 1995. A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc. Natl. Acad. Sci. USA. 92:7976-7980.
13. INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science (Wash. DC). 269:1281-1284.
14. Belldegrun, A., L.M. Muul, and S.A. Rosenberg. 1988. Interleukin-2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activity. Cancer Res. 48:206-214.
15. Balch, C.M., L.B. Riley, Y.J. Bae, M.A. Salmeron, C.D. Platsoucas, A. von Eschenbach, and K. Itoh. 1990. Patterns of human tumor-infiltrating lymphocytes in 120 human cancers. Arch. Surg. 125:200-205.
16. Montie, J.E., B.H. Stewart, R.A. Straffon, L.H.W. Banowsky, C.B. Hewitt, and D.K. Montague. 1977. The role of adjunctive nephrectomy in patients with metastatic renal cell carcinoma. J. Urol. 117:272-275.
17. Oliver, R.T.D., A.B.W. Nethersell, and J.M. Bottomley. 1989. Unexplained spontaneous regression and alpha-interferon as treatment for metastatic renal carcinoma. Br. J. Urol. 63:128-131.
18. Baldo, M., M. Schiavon, P.A. Cicogna, P. Boccato, and F. Mazzoleni. 1991. Spontaneous regression of subcutaneous metastasis of cutaneous melanoma. Plast. Reconstr. Surg. 90: 1073-1076.
19. Rosenberg, S.A. 1992. The immunotherapy and gene therapy of cancer. J. Clin. Oncol. 10:180-199.
20. Rosenberg, S.A., J.C. Yang, S.L. Topalian, D.J. Schwartzentruber, J.S. Weber, D.R. Parkinson, C.A. Seipp, J.H. Einhorn, and D.E. White. 1994. Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2. J. Am. Med. Assoc. 271:907-913.
21. Van den Eynde, B., P. Hainaut, M. Hérin, A. Knuth, C. Lemoine, P. Weynants, P. van der Bruggen, R. Fauchet, and T. Boon. 1989. Presence on a human melanoma of multiple antigens recognized by autologous CTL. Int. J. Cancer. 44: 634-640.
22. Boon, T., J. Van Snick, A. Van Pel, C. Uyttenhove, and M. Marchand. 1980. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis. J. Exp. Med. 152:1184-1193.
23. Espevik, T., and J. Nissen-Meyer. 1986. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods. 95:99-105.
24. Hansen, M.B., S.E. Nielsen, and K. Berg. 1989. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods. 119:203-210.
25. Barnstable, C.J., W.F. Bodmer, G. Brown, G. Galfre, C. Milstein, A.F. Williams, and A. Ziegler. 1978. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell-surface antigens - new tools for genetic analysis. Cell. 14:9-20.
26. Lampson, L.A., and R. Levy. 1980. Two populations of Ia-like molecules on a human B cell line. J. Immunol. 125:293-299.
27. Parham, P., and F.M. Brodsky. 1981. Partial purification and some properties of BB7.2. A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28. Hum. Immunol 3:277-299.
28. Davis, L.G., M.D. Dibner, and J.F. Battey. 1986. Basic Methods in Molecular Biology. Elsevier Science Publishing Co., Inc., New York. 130-135.
29. Seed, B., and A. Aruffo. 1987. Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure. Proc. Natl. Acad. Sci. USA. 84:3365-3369.
30. Viret, C., F. Davodeau, Y. Guilloux, J.-D. Bignon, G. Semana, R. Breathnach, and F. Jotereau. 1993. Recognition of shared melanoma antigen by HLA-A2-restricted cytolytic T cell clones derived from human tumor-infiltrating lymphocytes. Eur. J. Immunol. 23:141-146.
31. Ennis, P.D., J. Zemmour, R.D. Salter, and P. Parham. 1990. Rapid cloning of HLA-A,B cDNA by using the polymerase chain reaction: frequency and nature of errors produced in amplification. Proc. Natl. Acad. Sci. USA. 87:2833-2837.
32. Russo, C., A.-K. Ng, M.A. Pellegrino, and S. Ferrone. 1983. The monoclonal antibody CR11-351 discriminates HLA-A2 variants identified by T cells. Immunogenetics. 18:23-35.
33. McMichael, A.J., P. Parham, N. Rust, and F.M. Brodsky. 1980. A monoclonal antibody that recognizes an antigenic determinant shared by HLA-A2 and B17. Hum. Immunol. 1: 121-129.
34. Parham, P., and W.F. Bodmer. 1978. Monoclonal antibody to a human histocompatibility alloantigen, HLA-A2. Nature (Lond.). 276:397-399.
35. Santos-Aguado, J., J.A. Barbosa, P.A. Biro, and J.L. Strominger. 1988. Molecular characterization of serologic recognition sites in the human HLA-A2 molecule. J. Immunol. 141:2811-2818.
36. Lombardi, G., M. Matsui, R. Moots, G. Aichinger, S. Sidhu, R. Batchelor, J. Frelinger, and R. Lechler. 1991. Limited regions of the α2-domain α-helix control anti-A2 allorecognition: an analysis using a panel of A2 mutants.Immunogenetics. 34:149-156.
37. - mutation. Proc. Natl. Acad. Sci. USA. 85:2274-2278.
38. Boon, T. 1992. Toward a genetic analysis of tumor rejection antigens. Adv. Cancer Res. 58:177-210.
39. Mandelboim, O., G. Berke, M. Fridkin, M. Feldman, M. Eisenstein, and L. Eisenbach. 1994. CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma. Nature (Lond.). 369:67-71.
40. Monach, P.A., S.C. Meredith, C.T. Siegel, and H. Schreiber. 1995. A unique tumor antigen produced by a single amino acid substitution. Immunity. 2:45-59.
41. Invernizzi, G., and G. Parmiani. 1975. Tumour-associated transplantation antigens of chemically induced sarcomata cross reacting with allogeneic histocompatibility antigens. Nature (Lond.). 254:713-714.
42. Parham, P. 1989. Alien antigens return to the fold. Immunol. Today. 10:206-212.
43. Linsley, P.S., and J.A. Ledbetter. 1993. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11:191-212.
44. lck in T-cells infiltrating human renal cell carcinoma. Cancer Res. 53: 5613-5616.
45. Tartour, E., S. Latour, C. Mathiot, N. Thiounn, V. Mosseri, I. Joyeux, C. Dubois D'Enghien, R. Lee, B. Debre, and W.H. Fridman. 1995. Variable expression of CD3-ζ chain in tumor-infiltrating lymphocytes (TIL) derived from renal-cell carcinoma: relationship with TIL phenotype and function. Int. J. Cancer. 63:205-212.
46. Chen, L., S. Ashe, W.A. Brady, I. Hellström, K.E. Hellström, J.A. Ledbetter, P. McGowan, and P.S. Linsley. 1992. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell. 71:1093-1102.
47. + T cells by B7-transfected melanoma cells. Science (Wash. DC). 259:368-370.
48. Sprent, J., M. Hurd, M. Schaefer, and W. Heath. 1995. Split tolerance in spleen chimeras. J. Immunol. 154:1198-1206.
49. Hoffmann, M.W., W.R. Heath, D. Ruschmeyer, and J.F.A.P. Miller. 1995. Deletion of high-avidity T cells by thymic epithelium. Proc. Natl. Acad. Sci. USA. 92:9851-9855.
50. Prehn, R.T., and J.M. Main. 1957. Immunity to methylcholanthrene-induced sarcomas. J. Natl. Cancer Inst. 18:769-778.
51. Aaltonen, L.A., P. Peltomäki, F.S. Leach, P. Sistonen, L. Pylkkänen, J.-P. Mecklin, H. Järvinen, S.M. Powell, J. Jen, S.R. Hamilton, et al. 1993. Clues to the pathogenesis of familial colorectal cancer. Science (Wash. DC). 260:812-816.
52. Thibodeau, S.N., G. Bren, and D. Schaid. 1993. Microsatellite instability in cancer of the proximal colon. Science (Wash. DC). 260:816-819.
53. Ionov, Y., M.A. Peinado, S. Malkhosyan, D. Shibata, and M. Perucho. 1993. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature (Lond.). 363:558-561.
54. Han, H.-J., A. Yanagisawa, Y. Kato, J.-G. Park, and Y. Nakamura. 1993. Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer. Cancer Res. 53: 5087-5089.
55. Modrich, P. 1994. Mismatch repair, genetic stability, and cancer. Science (Wash. DC). 266:1959-1960.